Patient Safety and Medication Errors

Learning representations by back-propagating errors

The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Estimating Standard Errors in Finance Panel Data Sets: Comparing Approaches

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

<scp>micro</scp>‐<scp>checker</scp>: software for identifying and correcting genotyping errors in microsatellite data

Psychological Safety and Learning Behavior in Work Teams

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Space/time trade-offs in hash coding with allowable errors

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS

Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials

THE VALUATION OF RISK ASSETS AND THE SELECTION OF RISKY INVESTMENTS IN STOCK PORTFOLIOS AND CAPITAL BUDGETS**This paper is another in a series of interrelated theoretical and statistical studies of corporate financial and investment policies being made under grants from the Rockefeller Foundation, and more recently the Ford Foundation, to the Harvard Business School. The generous support for this work is most gratefully acknowledged. The author is also much indebted to his colleagues Professors Bishop, Christenson, Kahr, Raiffa, and (especially) Schlaifer, for extensive discussion and commentary on an earlier draft of this paper; but responsibility for any errors or imperfections remains strictly his own.[Professor Sharpe's paper, “Capital Asset Prices: A Theory of Market Equilibrium Under Conditions of Risk” (Journal of Finance, September 1964) appeared after this paper was in final form and on its way to the printers. My first section, which parallels the first half of his paper (with corresponding conclusions), sets the algebraic framework for sections II, III and VI, (which have no counterpart in his paper) and for section IV on the equilibrium prices of risk assets, concerning which our results differ significantly for reasons which will be explored elsewhere. Sharpe does not take up the capital budgeting problem developed in section V below.]

A review of methods for the assessment of prediction errors in conservation presence/absence models

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Adherence to Medication

Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

The Patient Health Questionnaire-2